Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing
Muhammad Naeem, Saman Majeed, Mubasher Zahir Hoque, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1608-1608
Open Access | Times Cited: 372

Showing 26-50 of 372 citing articles:

Evolution of CRISPR/Cas Systems for Precise Genome Editing
Magdalena Hryhorowicz, Daniel Lipiński, Joanna Zeyland
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14233-14233
Open Access | Times Cited: 27
Recent Advances in Genome-Engineering Strategies
Michaela A. Boti, Konstantina Athanasopoulou, Panagiotis G. Adamopoulos, et al.
Genes (2023) Vol. 14, Iss. 1, pp. 129-129
Open Access | Times Cited: 24
Optimizing CRISPR/Cas9 precision: Mitigating off-target effects for safe integration with photodynamic and stem cell therapies in cancer treatment
J. P. Jose Merlin, Heidi Abrahamse
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117516-117516
Open Access | Times Cited: 13
The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
Yekta Metanat, Patrik Viktor, Ayesha Amajd, et al.
Life Sciences (2024) Vol. 348, pp. 122683-122683
Closed Access | Times Cited: 12
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
Shiyao Zhou, Yingjie Li, Qinjie Wu, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
Revolutionizing in vivo therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges
Arturo Macarrón Palacios, Patrick Korus, Bodo G. C. Wilkens, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 11
Emerging strategies for nanomedicine in autoimmunity
Ajay S. Thatte, Margaret M. Billingsley, Drew Weissman, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115194-115194
Closed Access | Times Cited: 11
Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging
Asif Ahmad Bhat, Ehssan Moglad, Ahsas Goyal, et al.
Life Sciences (2024) Vol. 357, pp. 123056-123056
Closed Access | Times Cited: 10
From Origin to the Present: Establishment, Mechanism, Evolutions and Biomedical Applications of the CRISPR/Cas-Based Macromolecular System in Brief
Zheng Yuan
Molecules (2025) Vol. 30, Iss. 4, pp. 947-947
Open Access | Times Cited: 1
Engineering Useful Microbial Species for Pharmaceutical Applications
А.К. САДАНОВ, B.B. BAIMAKHANOVA, Saltanat Emilievna Orasymbet, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 599-599
Open Access | Times Cited: 1
Applications and Potential of Genome-Editing Systems in Rice Improvement: Current and Future Perspectives
Javaria Tabassum, Shakeel Ahmad, Babar Hussain, et al.
Agronomy (2021) Vol. 11, Iss. 7, pp. 1359-1359
Open Access | Times Cited: 53
Plant Viruses: From Targets to Tools for CRISPR
Carla Varanda, Maria do Rosário Félix, Maria Doroteia Campos, et al.
Viruses (2021) Vol. 13, Iss. 1, pp. 141-141
Open Access | Times Cited: 48
Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
Xiaoqiang Huang, Dongshan Yang, Jifeng Zhang, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2186-2186
Open Access | Times Cited: 38
Hypercompact adenine base editors based on a Cas12f variant guided by engineered RNA
Do Yon Kim, Yuhee Chung, Yujin Lee, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 9, pp. 1005-1013
Open Access | Times Cited: 37
The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases
Juan Lou, Bin Wang, Junwei Li, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 12, pp. 11301-11311
Open Access | Times Cited: 35
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
Kun Huang, Daniel Zapata, Yan Tang, et al.
Biomaterials (2022) Vol. 291, pp. 121876-121876
Open Access | Times Cited: 33
Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy
Duohao Ren, Sylvain Fisson, Deniz Dalkara, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1973-1973
Open Access | Times Cited: 32
Gene Therapy Targeting PCSK9
Julius L. Katzmann, Arjen J. Cupido, Ulrich Laufs
Metabolites (2022) Vol. 12, Iss. 1, pp. 70-70
Open Access | Times Cited: 31
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
Tianxu Fang, Xiaona Cao, Mysha Ibnat, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 31
Effective use of sequence information to predict CRISPR-Cas9 off-target
Zhong-Rui Zhang, Zhenran Jiang
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 650-661
Open Access | Times Cited: 30
Deciphering the recent trends in pesticide bioremediation using genome editing and multi-omics approaches: a review
Shahnawaz Hassan, Bashir Ahmad Ganai
World Journal of Microbiology and Biotechnology (2023) Vol. 39, Iss. 6
Closed Access | Times Cited: 23
Gene Therapy and Gene Editing for β-Thalassemia
Georgios E. Christakopoulos, Rahul Telange, Jonathan Yen, et al.
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 2, pp. 433-447
Open Access | Times Cited: 22
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 22
CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics
Prashant Kumar Tiwari, Tin-Hsien Ko, Rajni Dubey, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 21
Oligodendrogenesis and myelination tracing in a CRISPR/Cas9-engineered brain microphysiological system
July Carolina Romero, Cynthia Berlinicke, Sharon Chow, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 20

Scroll to top